TT genotype of the MMP ‐9‐1562C/T polymorphism may be a risk factor for thrombolytic therapy‐induced hemorrhagic complications after acute ischemic stroke

ConclusionTT genotype of theMMP-9-1562C/T polymorphism may be a risk factor for rtPA-induced hemorrhagic complications after AIS.

Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - May 28, 2021 Category: Drugs & Pharmacology Authors: Marija Dusanovic Pjevic, Biljana Jekic, Ljiljana Beslac Bumbasirevic, Ljubica Vojvodic, Tatjana Damnjanovic, Milka Grk, Nela Maksimovic, Milica Pesic, Milica Gulic, Jelena Trickovic, Katarina Kacar Tags: ORIGINAL RESEARCH ARTICLE Source Type: research